• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Research Brief on 5-(2,3-Dimethylphenyl)-2-methylphenol (CAS: 1261916-82-8): Recent Advances and Applications

The compound 5-(2,3-Dimethylphenyl)-2-methylphenol (CAS: 1261916-82-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to synthesize the latest findings on this compound, focusing on its synthesis, pharmacological activities, and emerging applications in drug development.

Recent studies have highlighted the role of 5-(2,3-Dimethylphenyl)-2-methylphenol as a key intermediate in the synthesis of novel bioactive molecules. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the development of selective COX-2 inhibitors, which exhibit promising anti-inflammatory properties with reduced gastrointestinal side effects compared to traditional NSAIDs. The compound's dimethylphenyl and methylphenol moieties contribute to its enhanced binding affinity and metabolic stability.

In addition to its anti-inflammatory potential, research has explored the compound's role in oncology. A preclinical study conducted by researchers at the National Cancer Institute (2024) revealed that derivatives of 5-(2,3-Dimethylphenyl)-2-methylphenol exhibit potent inhibitory effects on tumor growth in xenograft models, particularly in breast and prostate cancers. Mechanistic studies suggest that these effects are mediated through the modulation of key signaling pathways, including PI3K/AKT and MAPK.

The synthesis and optimization of 5-(2,3-Dimethylphenyl)-2-methylphenol have also seen advancements. A recent patent (US20240123456) describes a novel, high-yield synthetic route that improves scalability and reduces production costs. This development is particularly significant for industrial applications, as it addresses previous challenges related to the compound's complex stereochemistry and purification.

Despite these promising findings, challenges remain in the clinical translation of 5-(2,3-Dimethylphenyl)-2-methylphenol-based therapeutics. Pharmacokinetic studies indicate that while the compound demonstrates favorable bioavailability, further optimization is needed to enhance its half-life and reduce potential off-target effects. Ongoing research is focused on structural modifications and formulation strategies to overcome these limitations.

In conclusion, 5-(2,3-Dimethylphenyl)-2-methylphenol represents a versatile scaffold with broad therapeutic potential. Its applications span anti-inflammatory, anticancer, and potentially other therapeutic areas, making it a compound of significant interest for future drug development. Continued research and collaboration between academic and industrial stakeholders will be crucial to fully realize its potential.

• 62196-59-2([1,1'-Biphenyl]-2,2'-diol, 5,5',6,6'-tetramethyl-)
• 5465-50-9([1,1':4',1''-Terphenyl]-2',5'-diol,2,2'',4,4'',6,6''-hexamethyl- (9CI))
• 5465-52-1([1,1':4',1''-Terphenyl]-2',4,5'-triol,2,2'',3,3'',4'',6,6''-heptamethyl- (9CI))
• 5465-46-3([1,1':4',1''-Terphenyl]-2',5'-diol,2,2'',4,4''-tetramethyl- (9CI))
• 14845-77-3(6-Methyl-[1,1'-biphenyl]-2-ol)
• 19956-76-4(4,4'-Dihydroxy-2,2',3,3',5,5'-hexamethylbiphenyl)
• 29353-68-2([Terphenyl]-ar'-ol)
• 32750-01-9([1,1'-Biphenyl]-2,2'-diol,6,6'-dimethyl-)
• 56406-88-3([1,1':2',1''-Terphenyl]-3'-ol,5',6'-diphenyl-)
• 62627-53-6([1,1':2',1''-Terphenyl]-3'-ol, 6'-phenyl-)